Search Results - "MESTECKY, Jiri"

Refine Results
  1. 1

    Antibody-dependent passive protection of mucosal surfaces by Mestecky, Jiri

    Published in Human vaccines & immunotherapeutics (29-04-2022)
    “…Extensive experiments performed mostly in a variety of animal models convincingly demonstrated the protective effect of polyclonal or monoclonal antibodies…”
    Get full text
    Journal Article
  2. 2

    Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection by Russell, Michael W, Moldoveanu, Zina, Ogra, Pearay L, Mestecky, Jiri

    Published in Frontiers in immunology (30-11-2020)
    “…The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat:…”
    Get full text
    Journal Article
  3. 3

    Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission by Russell, Michael W., Mestecky, Jiri

    Published in Frontiers in immunology (17-08-2022)
    “…SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on reaching the lungs causes the severe acute respiratory disease,…”
    Get full text
    Journal Article
  4. 4

    Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis by Russell, Michael W, Kilian, Mogens, Mestecky, Jiri

    Published in mBio (29-08-2024)
    “…Secretory (S) IgA antibodies against severe acute respiratory syndrome (SARS)-CoV-2 are induced in saliva and upper respiratory tract (URT) secretions by…”
    Get full text
    Journal Article
  5. 5

    Enhancing oral vaccine potency by targeting intestinal M cells by Azizi, Ali, Kumar, Ashok, Diaz-Mitoma, Francisco, Mestecky, Jiri

    Published in PLoS pathogens (01-11-2010)
    “…The immune system in the gastrointestinal tract plays a crucial role in the control of infection, as it constitutes the first line of defense against mucosal…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mucosal immunoglobulins by Woof, Jenny M., Mestecky, Jiri

    Published in Immunological reviews (01-08-2005)
    “…Due to their vast surface area, the mucosal surfaces of the body represent a major site of potential attack by invading pathogens. The secretions that bathe…”
    Get full text
    Journal Article
  8. 8

    The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy by Knoppova, Barbora, Reily, Colin, Maillard, Nicolas, Rizk, Dana V, Moldoveanu, Zina, Mestecky, Jiri, Raska, Milan, Renfrow, Matthew B, Julian, Bruce A, Novak, Jan

    Published in Frontiers in immunology (12-04-2016)
    “…IgA nephropathy (IgAN) is the most common primary glomerulonephritis, frequently leading to end-stage renal disease, as there is no disease-specific therapy…”
    Get full text
    Journal Article
  9. 9

    IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy by Novak, Jan, PhD, Julian, Bruce A., MD, Tomana, Milan, PhD, Mestecky, Jiri, MD, PhD

    Published in Seminars in nephrology (2008)
    “…Summary Circulating immune complexes containing aberrantly glycosylated IgA1 play a pivotal role in the pathogenesis of IgA nephropathy (IgAN). A portion of…”
    Get full text
    Journal Article
  10. 10

    IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease by Mestecky, Jiri, Julian, Bruce A, Raska, Milan

    Published in Frontiers in immunology (07-02-2023)
    “…IgA nephropathy (IgAN) is an autoimmune disease in which poorly galactosylated IgA1 is the antigen recognized by naturally occurring anti-glycan antibodies,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    IgA nephropathy: molecular mechanisms of the disease by Mestecky, Jiri, Raska, Milan, Julian, Bruce A, Gharavi, Ali G, Renfrow, Matthew B, Moldoveanu, Zina, Novak, Lea, Matousovic, Karel, Novak, Jan

    Published in Annual review of pathology (24-01-2013)
    “…Studies of molecular and cellular interactions involved in the pathogenesis of IgA nephropathy have revealed the autoimmune nature of this most common primary…”
    Get full text
    Journal Article
  13. 13

    Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier? by Mestecky, Jiri, Russell, Michael W, Elson, Charles O

    Published in The Journal of immunology (1950) (01-11-2007)
    “…Mucosal administration of Ags induces specific Abs in external secretions and systemic unresponsiveness termed oral or mucosal tolerance. The dominant response…”
    Get full text
    Journal Article
  14. 14

    Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy by GHARAVI, Ali G, MOLDOVEANU, Zina, WYATT, Robert J, BARKER, Catherine V, WOODFORD, Susan Y, LIFTON, Richard P, MESTECKY, Jiri, NOVAK, Jan, JULIAN, Bruce A

    “…IgA nephropathy (IgAN) is a complex trait determined by genetic and environmental factors. Most IgAN patients exhibit a characteristic undergalactosylation of…”
    Get full text
    Journal Article
  15. 15

    Glycosylation of IgA1 and pathogenesis of IgA nephropathy by Novak, Jan, Julian, Bruce A., Mestecky, Jiri, Renfrow, Matthew B.

    Published in Seminars in immunopathology (01-05-2012)
    “…IgA nephropathy, described in 1968 as IgA-IgG immune-complex disease, is an autoimmune disease. Galactose-deficient IgA1 is recognized by unique…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy by Zachova, Katerina, Kosztyu, Petr, Zadrazil, Josef, Matousovic, Karel, Vondrak, Karel, Hubacek, Petr, Julian, Bruce A, Moldoveanu, Zina, Novak, Zdenek, Kostovcikova, Klara, Raska, Milan, Mestecky, Jiri

    Published in Frontiers in immunology (28-02-2020)
    “…IgA nephropathy (IgAN) is the dominant type of primary glomerulonephritis worldwide. However, IgAN rarely affects African Blacks and is uncommon in African…”
    Get full text
    Journal Article
  19. 19
  20. 20